Redhill Biopharma Ltd (RDHL) — Working Capital to Net Assets Ratio
Redhill Biopharma Ltd (RDHL) has a Working Capital to Net Assets ratio of 220.6% as of June 2025. Working capital of $-9.73 Million (current assets of $12.55 Million minus current liabilities of $22.29 Million) is measured against net assets of $-4.41 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See Redhill Biopharma Ltd balance sheet quality to measure how much of total assets are equity-financed.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Redhill Biopharma Ltd Working Capital to Net Assets (2011–2024)
This chart shows how Redhill Biopharma Ltd's Working Capital to Net Assets ratio has evolved across 14 annual periods from 2011 to 2024. As of June 2025, the ratio stands at 220.6%, reflecting working capital of $-9.73 Million against net assets of $-4.41 Million USD. Check Redhill Biopharma Ltd tangible book value ratio to evaluate the tangible quality of the company's equity base.
Annual Working Capital to Net Assets for Redhill Biopharma Ltd (2011–2024)
The table below presents the year-by-year Working Capital to Net Assets ratio for Redhill Biopharma Ltd from 2011 to 2024, covering 14 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see how much is Redhill Biopharma Ltd worth.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 220.2% | $-10.31 Million | $-4.68 Million | $11.91 Million | $22.22 Million | ▲ +370.1 pp |
| 2023 | -149.9% | $-3.10 Million | $2.07 Million | $16.14 Million | $19.24 Million | ▼ -380.4 pp |
| 2022 | 230.5% | $-111.55 Million | $-48.40 Million | $85.90 Million | $197.45 Million | ▲ +143.9 pp |
| 2021 | 86.6% | $7.68 Million | $8.88 Million | $89.15 Million | $81.47 Million | ▲ +106.3 pp |
| 2020 | -19.8% | $-2.74 Million | $13.86 Million | $70.50 Million | $73.23 Million | ▼ -90.8 pp |
| 2019 | 71.0% | $42.60 Million | $60.00 Million | $53.21 Million | $10.62 Million | ▼ -19.7 pp |
| 2018 | 90.7% | $46.41 Million | $51.19 Million | $56.79 Million | $10.38 Million | ▲ +2.2 pp |
| 2017 | 88.4% | $39.85 Million | $45.06 Million | $51.68 Million | $11.83 Million | ▼ -11.2 pp |
| 2016 | 99.6% | $62.46 Million | $62.70 Million | $67.81 Million | $5.36 Million | ▲ +8.1 pp |
| 2015 | 91.5% | $55.00 Million | $60.08 Million | $60.51 Million | $5.51 Million | ▼ -5.6 pp |
| 2014 | 97.2% | $24.30 Million | $25.01 Million | $26.02 Million | $1.72 Million | ▲ +11.7 pp |
| 2013 | 85.4% | $10.19 Million | $11.93 Million | $12.60 Million | $2.42 Million | ▼ -6.5 pp |
| 2012 | 91.9% | $17.48 Million | $19.02 Million | $18.56 Million | $1.08 Million | ▼ -5.1 pp |
| 2011 | 97.0% | $18.22 Million | $18.79 Million | $18.74 Million | $513.00K | — |